Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06263907

Stellate Ganglion Block for Prevention of Post Mastectomy Depression

Preemptive Efficacy of Stellate Ganglion Block for Prevention of Post Mastectomy Depression

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Complications after mastectomy include chronic pain and depression.

Detailed description

A mastectomy is surgery could be associated with complications include chronic pain and depression. In female breast cancer patients, the incidence of postoperative depression was 46.55%. Stellate ganglion block had been used for treating post-traumatic stress disorder (PTSD) and depression symptoms even in its prevention. Also, it used in treatment of chronic pain.

Conditions

Interventions

TypeNameDescription
PROCEDUREStellate gangalion blockThe efficacy of Preoperative ipsilateral stellate gangalion block on the occurrence of postmastectomy depression and pain compared with no block

Timeline

Start date
2024-03-01
Primary completion
2027-11-30
Completion
2028-12-30
First posted
2024-02-16
Last updated
2026-02-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06263907. Inclusion in this directory is not an endorsement.